Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 34 n° 276

Pfizer and Allergan merger makes sense in an industry forcing a race for scale

Posted by fidest press agency su martedì, 24 novembre 2015

Expert comment on the newly announced merger between Pfizer and Allergan, John Colley, Professor of Practice at Warwick Business School and an expert on large-scale mergers, has made the following comments:”Botox producer Allergan has been acquired for $160Bn by Pfizer to make it the world’s largest pharmaceutical business. This deal follows a pattern in which the pharmaceutical industry has seen acquisitions totalling over $600Bn this year as the industry consolidates. “Industry valuations increase as industry players become concerned at being left behind in the race for scale. In the instance of Pfizer it is also pursuing greater growth as its own established products are losing patent protection at a greater rate than it can produce innovative products. “Allergan’s drug portfolio has greater potential for growth. In addition the lure of tax advantages from a Dublin Head Office has been a significant factor in driving this deal. The threat of succumbing to US tax rates has meant that Pfizer has been desperate for a deal outside the U.S. The failure of the AstraZeneca bid in a consolidating industry has driven the substantial price paid for Allergan.”In a year in which low interest rates, relatively benign markets, reasonable growth prospects and institutions awash with cash there is likely to be a record number of deals exceeding the previous record of $4.6 Trillion in 2007. “Most deals this year have been consolidations within an industry which have a clear strategic logic and as a consequence slightly lower risk. AB InBev and SAB Miller, Dell and EMC, Holcim and Lafarge are designed to exploit greater market power through size and generate substantial cost savings through scale and scope economies. Head Office and Regional management are generally key targets.”Both institutions and businesses draw confidence from ‘strength in numbers’ which encourages more deals. Despite the enormous risks associated with acquisitions in which over half destroy value and 60 to 80% materially fail to deliver expected benefits the rush goes on. “Research shows that the biggest reason for acquisitions failing to deliver benefits is simply paying too much! One wonders how many of the 2015 deals will ultimately fail to deliver value. My money is on more than half.”
Warwick Business School, located in central England, is the largest department of the University of Warwick and the UK’s fastest rising business school according the Financial Times. WBS is triple accredited by the leading global business education associations and was the first in the UK to attain this accreditation. Offering the full portfolio of business education courses, from undergraduate through to MBAs, and with a strong Doctoral Programme, WBS is the complete business school. Students at WBS currently number around 6,500, and come from 125 countries. Just under half of faculty are non-UK, or have worked abroad. WBS Dean, Professor Mark P Taylor, is among the most highly-cited scholars in the world and was previously Managing Director at BlackRock, the world’s largest asset manager.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: